Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
复制标题
DOI:
10.1038/s41375-021-01212-6
复制
发表时间:
2021-11
期刊:
影响因子:
11.4
通讯作者:
Klco JM
中科院分区:
文献类型:
--
作者:
Thomas ME 3rd;Abdelhamed S;Hiltenbrand R;Schwartz JR;Sakurada SM;Walsh M;Song G;Ma J;Pruett-Miller SM;Klco JM
Pediatric myelodysplastic syndromes (MDS) are a heterogeneous disease group associated with impaired hematopoiesis, bone marrow hypocellularity, and frequently have deletions involving chromosome 7 (monosomy 7). We and others recently identified heterozygous germline mutations in SAMD9 and SAMD9L in children with monosomy 7 and MDS. We previously demonstrated an antiproliferative effect of these gene products in non-hematopoietic cells, which was exacerbated by their patient-associated mutations. Here, we used a lentiviral overexpression approach to assess the functional impact and underlying cellular processes of wild-type and mutant SAMD9 or SAMD9L in primary mouse or human hematopoietic stem and progenitor cells (HSPC). Using a combination of protein interactome analyses, transcriptional profiling, and functional validation, we show that SAMD9 and SAMD9L are multifunctional proteins that cause profound alterations in cell cycle, cell proliferation, and protein translation in HSPCs. Importantly, our molecular and functional studies also demonstrated that expression of these genes and their mutations leads to a cellular environment that promotes DNA damage repair defects and ultimately apoptosis in hematopoietic cells. This study provides novel functional insights into SAMD9 and SAMD9L and how their mutations can potentially alter hematopoietic function and lead to bone marrow hypocellularity, a hallmark of pediatric MDS.
登录
查看更多内容
影响因子:
4.4
作者:
Li CF;MacDonald JR;Wei RY;Ray J;Lau K;Kandel C;Koffman R;Bell S;Scherer SW;Alman BA
通讯作者:
Alman BA
影响因子:
16.6
作者:
Alvarez S;Díaz M;Flach J;Rodriguez-Acebes S;López-Contreras AJ;Martínez D;Cañamero M;Fernández-Capetillo O;Isern J;Passegué E;Méndez J
通讯作者:
Méndez J
DOI:
10.1172/jci91913
发表时间:
2017-05-01
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Buonocore F;Kühnen P;Suntharalingham JP;Del Valle I;Digweed M;Stachelscheid H;Khajavi N;Didi M;Brady AF;Blankenstein O;Procter AM;Dimitri P;Wales JKH;Ghirri P;Knöbl D;Strahm B;Erlacher M;Wlodarski MW;Chen W;Kokai GK;Anderson G;Morrogh D;Moulding DA;McKee SA;Niemeyer CM;Grüters A;Achermann JC
通讯作者:
Achermann JC
影响因子:
6.7
作者:
Meng X;Zhang F;Yan B;Si C;Honda H;Nagamachi A;Sun LZ;Xiang Y
通讯作者:
Xiang Y
影响因子:
3.6
作者:
Niemeyer, Charlotte M.;Baumann, Irith
通讯作者:
Baumann, Irith